Burrage Capital Management LLC Q3 2021 significant ownership

Burrage Capital Management LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Burrage Capital Management LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Protalix BioTherapeutics, Inc.^{Sold out}	July 30, 2021	0	0.0%
IVERIC bio, Inc.	February 14, 2020	10	3.4%

Compare quarters

Export Burrage Capital Management LLC's holdings